Search

Filters

Clear All
  • 14
  • 49
  • 620

Phase

  • 10
  • 16
  • 56
  • 9
  • 74
  • 3
  • 501
  • 597
  • 281
  • 669
  • 14
  • 683

Found 683 results for in-health

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

A Prospective, Multi-Center, Open-Label Clinical Investigation and Longitudinal Registry of the Cleaner Vac® Thrombectomy System for Peripheral Venous Thrombus Removal, Including a Subgroup Analysis of Patients With Lower Extremity Proximal Deep Vein Thrombosis

S
Sabah D. Butty, MD
18 years - 100 years
All genders
Observational
The primary objective of this clinical investigation is to evaluate the safety and effectiveness of the Cleaner Vac Thrombectomy System for the removal of thrombus in the peripheral venous vasculature in a real-world, all-comers population. This prospective, multi-center, open-label study will assess clinical outcomes, device performance, and procedural success across …
Learn More

A Randomized Phase II Study Comparing Cytarabine + Daunorubicin(7+3) vs (Daunorubicin and Cytarabine) Liposome, Cytarabine + Daunorubicin +Venetoclax, Azacitidine + Venetoclax, and (Daunorubicin and Cytarabine) Liposome+ Venetoclax in Patients Aged 59 or Younger Who are Considered High-Risk(Adverse) Acute Myeloid Leukemia as Determined by MYELOMATCH; AMyeloMATCH Clinical Trial

R
Rita Assi
18 years - 59 years
All genders
Phase 2
What is the purpose of this study?This phase II MyeloMATCH treatment trial tests whether the standard approach of cytarabine and daunorubicin in comparison to the following experimental regimens works to shrink cancer in patients with high risk acute myeloid leukemia (AML): 1) daunorubicin and cytarabine liposome alone; 2) cytarabine and …
Learn More

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

J
Jessica Parker Metter
18 years - 100 years
Female
Phase 3
Interventional
What is the purpose of this study?The OnPrime study is a multi-center, randomized open-label phase 3 study evaluating the safety and efficacy of Olvi-Vec followed by platinum-doublet chemotherapy and bevacizumab compared to the Active Comparator Arm with Physician's Choice of chemotherapy and bevacizumab in women diagnosed with platinum-resistant/refractory ovarian cancer …
Learn More
681 - 683 of 683